Aier Eye Hospital Group Co (300015) H2 2024 earnings summary

Executive summary

• Achieved revenue of ¥20.98 billion in 2024, up 3.02% year-over-year; net profit attributable to shareholders rose 5.87% to ¥3.56 billion.

• Operating profit declined 2.49% year-over-year; net profit margin increased to 16.8%.

• Outpatient visits reached 16.94 million, up 12.14%; surgeries totaled 1.29 million, up 9.38%.

• Continued expansion with 87 new medical institutions acquired and international presence strengthened.

Financial highlights

• Revenue: ¥20.98 billion (+3.02% YoY); net profit attributable: ¥3.56 billion (+5.87% YoY).

• Operating cash flow: ¥4.88 billion, down 16.86% YoY.

• Gross margin: 48.12%; basic EPS: ¥0.3847 (+5.57% YoY).

• Total assets: ¥33.26 billion (+10.17% YoY); net assets: ¥20.71 billion (+9.86% YoY).

• R&D investment: ¥320.6 million, 1.53% of revenue.

Outlook and guidance

• Focus on high-quality growth, digital transformation, and international expansion over the next three years.

• Targeting improved clinical, teaching, research, and service capabilities; continued investment in AI and digital health.

• 2025 goals include organizational reform, enhanced management efficiency, and further expansion of flagship hospitals.